# Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)

> **NCT00127114** · PHASE4 · WITHDRAWN · sponsor: **Johns Hopkins University**

## Conditions studied

- Dementia

## Interventions

- **DRUG:** Amantadine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00127114
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-09
- **Primary completion:** 2007-07-26
- **Final completion:** 2007-07-26
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No funding and exclusion criteria were to stringent.
- **Last updated:** 2017-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00127114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00127114, "Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00127114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*